Helping Animals Move Better, for Longer

Arthramid has been available to New Zealand veterinarians since 2020, supporting horses and dogs* affected by joint lameness and osteoarthritis.

Behind Arthramid in New Zealand and Australia is a team of experienced veterinarians committed to advancing long-term joint health through education, research, and clinical support.

Dr Jason Lowe and Dr Leigh de Clifford work closely with veterinarians, owners, trainers, and performance horses across Australasia while continuing to support ongoing education and collaboration with international research and veterinary partners.

Their hands-on clinical experience, combined with a strong focus on evidence-based medicine, helps ensure veterinarians across New Zealand and Australia have access to practical guidance and long-term support when using 2.5% iPAAG.

Arthramid is developed by Contura Vet, a company with more than 25 years of experience in joint health technologies across veterinary and human medicine.

Working alongside veterinary professionals around the world, Contura Vet continues to support ongoing research, clinical education, and innovation in long-term joint health.

This global research and manufacturing expertise helps ensure veterinarians across New Zealand and Australia have access to consistent product quality, evolving clinical knowledge, and long-term support.